Article info

Download PDFPDF

An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12 and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicity

Authors

  1. Correspondence toDr Mary O'Brien; Mary.O'Brien@rmh.nhs.uk
View Full Text

Citation

Minchom AR, Saksornchai K, Bhosle J, et al
An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12 and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicity

Publication history

  • Received August 27, 2014
  • Revised November 20, 2014
  • Accepted November 21, 2014
  • First published December 11, 2014.
Online issue publication 
December 11, 2014

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.